These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Disease specific therapies in leukodystrophies and leukoencephalopathies. Helman G; Van Haren K; Bonkowsky JL; Bernard G; Pizzino A; Braverman N; Suhr D; Patterson MC; Ali Fatemi S; Leonard J; van der Knaap MS; Back SA; Damiani S; Goldman SA; Takanohashi A; Petryniak M; Rowitch D; Messing A; Wrabetz L; Schiffmann R; Eichler F; Escolar ML; Vanderver A; Mol Genet Metab; 2015 Apr; 114(4):527-36. PubMed ID: 25684057 [TBL] [Abstract][Full Text] [Related]
5. Leukodystrophies: a proposed classification system based on pathological changes and pathogenetic mechanisms. van der Knaap MS; Bugiani M Acta Neuropathol; 2017 Sep; 134(3):351-382. PubMed ID: 28638987 [TBL] [Abstract][Full Text] [Related]
6. [Leukodystrophies: diseases of white matter of the nervous system]. Gärtner J; Kohlschütter A; Gieselmann V Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2007 Dec; 50(12):1531-40. PubMed ID: 18026884 [TBL] [Abstract][Full Text] [Related]
7. Quantitative MRI in leukodystrophies. Stellingwerff MD; Pouwels PJW; Roosendaal SD; Barkhof F; van der Knaap MS Neuroimage Clin; 2023; 38():103427. PubMed ID: 37150021 [TBL] [Abstract][Full Text] [Related]
8. Revised consensus statement on the preventive and symptomatic care of patients with leukodystrophies. Adang LA; Sherbini O; Ball L; Bloom M; Darbari A; Amartino H; DiVito D; Eichler F; Escolar M; Evans SH; Fatemi A; Fraser J; Hollowell L; Jaffe N; Joseph C; Karpinski M; Keller S; Maddock R; Mancilla E; McClary B; Mertz J; Morgart K; Langan T; Leventer R; Parikh S; Pizzino A; Prange E; Renaud DL; Rizzo W; Shapiro J; Suhr D; Suhr T; Tonduti D; Waggoner J; Waldman A; Wolf NI; Zerem A; Bonkowsky JL; Bernard G; van Haren K; Vanderver A; Mol Genet Metab; 2017 Sep; 122(1-2):18-32. PubMed ID: 28863857 [TBL] [Abstract][Full Text] [Related]
9. POLR3-Related Leukodystrophy: Exploring Potential Therapeutic Approaches. Perrier S; Michell-Robinson MA; Bernard G Front Cell Neurosci; 2020; 14():631802. PubMed ID: 33633543 [TBL] [Abstract][Full Text] [Related]
10. Childhood leukodystrophies: A literature review of updates on new definitions, classification, diagnostic approach and management. Ashrafi MR; Tavasoli AR Brain Dev; 2017 May; 39(5):369-385. PubMed ID: 28117190 [TBL] [Abstract][Full Text] [Related]
12. Recent Advancements in the Diagnosis and Treatment of Leukodystrophies. Bradbury AM; Ream MA Semin Pediatr Neurol; 2021 Apr; 37():100876. PubMed ID: 33892849 [TBL] [Abstract][Full Text] [Related]
13. Glial progenitor cell-based treatment of the childhood leukodystrophies. Osorio MJ; Goldman SA Exp Neurol; 2016 Sep; 283(Pt B):476-88. PubMed ID: 27170209 [TBL] [Abstract][Full Text] [Related]
14. Tools for diagnosis of leukodystrophies and other disorders presenting with white matter disease. Vanderver A Curr Neurol Neurosci Rep; 2005 Mar; 5(2):110-8. PubMed ID: 15743548 [TBL] [Abstract][Full Text] [Related]
15. Leukodystrophies: pathogenesis, diagnosis, strategies, therapies, and future research directions. Maria BL; Deidrick KM; Moser H; Naidu S J Child Neurol; 2003 Sep; 18(9):578-90. PubMed ID: 14572135 [No Abstract] [Full Text] [Related]